| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 18 | 2022 | 865 | 1.470 |
Why?
|
| Amyloid beta-Peptides | 16 | 2018 | 234 | 0.900 |
Why?
|
| Ethanol | 6 | 2003 | 168 | 0.840 |
Why?
|
| S100 Proteins | 4 | 2002 | 47 | 0.720 |
Why?
|
| Memory Disorders | 4 | 2013 | 209 | 0.680 |
Why?
|
| tau Proteins | 8 | 2022 | 237 | 0.650 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2009 | 295 | 0.650 |
Why?
|
| Serotonin Receptor Agonists | 5 | 2003 | 20 | 0.630 |
Why?
|
| Plaque, Amyloid | 6 | 2018 | 70 | 0.600 |
Why?
|
| Buspirone | 4 | 2002 | 13 | 0.580 |
Why?
|
| alpha-Synuclein | 6 | 2021 | 134 | 0.580 |
Why?
|
| Nerve Growth Factors | 4 | 2002 | 73 | 0.570 |
Why?
|
| Mice, Transgenic | 15 | 2022 | 2453 | 0.560 |
Why?
|
| Central Nervous System Depressants | 4 | 2003 | 22 | 0.560 |
Why?
|
| Neurodegenerative Diseases | 4 | 2012 | 281 | 0.540 |
Why?
|
| Imidazolidines | 1 | 2015 | 5 | 0.490 |
Why?
|
| Tromethamine | 1 | 2015 | 8 | 0.490 |
Why?
|
| Fixatives | 1 | 2015 | 14 | 0.490 |
Why?
|
| Astrocytes | 4 | 2003 | 270 | 0.490 |
Why?
|
| Histocytochemistry | 1 | 2015 | 92 | 0.480 |
Why?
|
| Formaldehyde | 1 | 2015 | 39 | 0.480 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 8 | 2008 | 305 | 0.480 |
Why?
|
| Ascorbic Acid | 1 | 2015 | 77 | 0.470 |
Why?
|
| Calcium-Binding Proteins | 3 | 2001 | 333 | 0.470 |
Why?
|
| Brain | 18 | 2021 | 3201 | 0.460 |
Why?
|
| Animals | 46 | 2025 | 34953 | 0.430 |
Why?
|
| Prostaglandins I | 1 | 2013 | 1 | 0.420 |
Why?
|
| Tauopathies | 1 | 2014 | 75 | 0.420 |
Why?
|
| Adenosine A1 Receptor Antagonists | 1 | 2013 | 2 | 0.410 |
Why?
|
| Xanthines | 1 | 2013 | 11 | 0.410 |
Why?
|
| Memory, Long-Term | 1 | 2013 | 34 | 0.400 |
Why?
|
| Parkinson Disease | 3 | 2005 | 739 | 0.400 |
Why?
|
| Physical Conditioning, Animal | 5 | 2020 | 85 | 0.390 |
Why?
|
| Disease Models, Animal | 14 | 2022 | 4694 | 0.380 |
Why?
|
| Behavior, Animal | 2 | 2013 | 506 | 0.360 |
Why?
|
| Neurons | 5 | 2009 | 2016 | 0.360 |
Why?
|
| Memory | 2 | 2018 | 355 | 0.360 |
Why?
|
| Nerve Tissue Proteins | 3 | 2013 | 1132 | 0.350 |
Why?
|
| Models, Biological | 2 | 2008 | 1441 | 0.350 |
Why?
|
| Mice | 27 | 2025 | 18566 | 0.330 |
Why?
|
| Endopeptidases | 5 | 2005 | 114 | 0.330 |
Why?
|
| Peptide Fragments | 7 | 2013 | 799 | 0.320 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2009 | 13 | 0.320 |
Why?
|
| Amyloid beta-Protein Precursor | 7 | 2012 | 133 | 0.310 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2025 | 391 | 0.300 |
Why?
|
| Raphe Nuclei | 3 | 2003 | 17 | 0.290 |
Why?
|
| Microglia | 1 | 2009 | 138 | 0.290 |
Why?
|
| Flurbiprofen | 2 | 2007 | 6 | 0.280 |
Why?
|
| Anxiety | 2 | 2013 | 1002 | 0.280 |
Why?
|
| Receptors, Serotonin | 3 | 2002 | 37 | 0.260 |
Why?
|
| Neurofibrillary Tangles | 1 | 2006 | 27 | 0.260 |
Why?
|
| Spinal Cord Injuries | 1 | 2009 | 261 | 0.250 |
Why?
|
| Neuroendocrine Secretory Protein 7B2 | 2 | 2018 | 2 | 0.250 |
Why?
|
| Ubiquitin | 2 | 2021 | 141 | 0.240 |
Why?
|
| Central Nervous System | 1 | 2007 | 283 | 0.240 |
Why?
|
| Quantum Dots | 1 | 2025 | 15 | 0.240 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2021 | 251 | 0.230 |
Why?
|
| Protein Precursors | 2 | 2006 | 156 | 0.210 |
Why?
|
| Gene Dosage | 1 | 2005 | 449 | 0.200 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2002 | 2 | 0.200 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2002 | 242 | 0.200 |
Why?
|
| Protease Inhibitors | 1 | 2003 | 97 | 0.200 |
Why?
|
| Rats | 9 | 2013 | 3612 | 0.190 |
Why?
|
| Neuroglia | 2 | 2003 | 214 | 0.190 |
Why?
|
| Cyclooxygenase 2 | 2 | 2021 | 127 | 0.180 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 4 | 2002 | 17 | 0.180 |
Why?
|
| Microscopy | 2 | 2019 | 126 | 0.180 |
Why?
|
| Indans | 1 | 2021 | 54 | 0.180 |
Why?
|
| Methylazoxymethanol Acetate | 1 | 2021 | 1 | 0.180 |
Why?
|
| Cycas | 1 | 2021 | 1 | 0.180 |
Why?
|
| Lactones | 1 | 2021 | 37 | 0.170 |
Why?
|
| Amyloid Precursor Protein Secretases | 6 | 2008 | 58 | 0.170 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2021 | 48 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2015 | 1225 | 0.170 |
Why?
|
| Sulfones | 1 | 2021 | 73 | 0.170 |
Why?
|
| Spinal Cord | 2 | 2014 | 276 | 0.170 |
Why?
|
| Central Nervous System Stimulants | 1 | 2001 | 128 | 0.170 |
Why?
|
| Optical Imaging | 1 | 2021 | 75 | 0.170 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2020 | 17 | 0.170 |
Why?
|
| Biocompatible Materials | 1 | 2021 | 126 | 0.160 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 161 | 0.160 |
Why?
|
| Enkephalins | 1 | 1999 | 19 | 0.160 |
Why?
|
| Fluorescent Dyes | 1 | 2021 | 265 | 0.160 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2020 | 126 | 0.160 |
Why?
|
| Nucleus Accumbens | 1 | 1999 | 56 | 0.150 |
Why?
|
| Nerve Degeneration | 2 | 2014 | 129 | 0.150 |
Why?
|
| Corpus Striatum | 1 | 1999 | 96 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 5 | 2018 | 4764 | 0.150 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 202 | 0.150 |
Why?
|
| Tissue Fixation | 2 | 2015 | 41 | 0.150 |
Why?
|
| Maze Learning | 3 | 2013 | 104 | 0.140 |
Why?
|
| Receptors, Serotonin, 5-HT1 | 3 | 2002 | 6 | 0.140 |
Why?
|
| Microvessels | 1 | 2018 | 66 | 0.140 |
Why?
|
| Liposomes | 2 | 2016 | 203 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 476 | 0.130 |
Why?
|
| CA1 Region, Hippocampal | 2 | 2013 | 67 | 0.120 |
Why?
|
| Angiotensins | 1 | 2015 | 8 | 0.120 |
Why?
|
| Paraffin Embedding | 1 | 2015 | 41 | 0.120 |
Why?
|
| Antigens | 1 | 2015 | 149 | 0.120 |
Why?
|
| Hot Temperature | 1 | 2015 | 142 | 0.120 |
Why?
|
| Biological Assay | 1 | 2016 | 111 | 0.120 |
Why?
|
| Polymyxin B | 1 | 2015 | 47 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 448 | 0.110 |
Why?
|
| Synucleins | 2 | 2005 | 15 | 0.110 |
Why?
|
| Cyclooxygenase 1 | 1 | 2013 | 27 | 0.110 |
Why?
|
| Drug Design | 2 | 2021 | 161 | 0.100 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2013 | 41 | 0.100 |
Why?
|
| Aspartic Acid Endopeptidases | 5 | 2005 | 34 | 0.100 |
Why?
|
| Hippocampus | 3 | 2013 | 819 | 0.100 |
Why?
|
| Humans | 26 | 2021 | 132105 | 0.100 |
Why?
|
| Amyloid | 1 | 2013 | 70 | 0.100 |
Why?
|
| Entorhinal Cortex | 1 | 2013 | 22 | 0.100 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2013 | 115 | 0.100 |
Why?
|
| Ethanolamines | 1 | 2012 | 25 | 0.100 |
Why?
|
| Sulindac | 2 | 2003 | 5 | 0.100 |
Why?
|
| Molecular Structure | 3 | 2021 | 322 | 0.100 |
Why?
|
| Presenilin-1 | 1 | 2012 | 57 | 0.100 |
Why?
|
| Nanoparticles | 1 | 2016 | 288 | 0.100 |
Why?
|
| Motor Activity | 2 | 2013 | 521 | 0.100 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2012 | 51 | 0.100 |
Why?
|
| Autophagy | 1 | 2016 | 427 | 0.090 |
Why?
|
| Pregnancy | 6 | 2003 | 7551 | 0.090 |
Why?
|
| Dementia | 2 | 2008 | 475 | 0.090 |
Why?
|
| RNA, Messenger | 4 | 2006 | 2679 | 0.090 |
Why?
|
| Fear | 1 | 2013 | 205 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2002 | 3061 | 0.090 |
Why?
|
| Mutation | 5 | 2009 | 6249 | 0.090 |
Why?
|
| Interneurons | 1 | 2013 | 147 | 0.090 |
Why?
|
| Culture Media, Conditioned | 2 | 2001 | 83 | 0.090 |
Why?
|
| Neural Pathways | 1 | 2013 | 281 | 0.090 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 2 | 2000 | 12 | 0.080 |
Why?
|
| Female | 18 | 2018 | 70680 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 3854 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2003 | 419 | 0.070 |
Why?
|
| Stereoisomerism | 2 | 2007 | 119 | 0.070 |
Why?
|
| CHO Cells | 5 | 2008 | 158 | 0.070 |
Why?
|
| Cricetinae | 5 | 2008 | 381 | 0.070 |
Why?
|
| Motor Skills Disorders | 1 | 2006 | 9 | 0.060 |
Why?
|
| Cell Line | 3 | 2013 | 2730 | 0.060 |
Why?
|
| Urease | 1 | 2006 | 74 | 0.060 |
Why?
|
| Carbazoles | 1 | 2006 | 29 | 0.060 |
Why?
|
| Fabaceae | 1 | 2006 | 21 | 0.060 |
Why?
|
| Encephalitis | 1 | 2007 | 118 | 0.060 |
Why?
|
| Neoplasms | 1 | 2021 | 2953 | 0.060 |
Why?
|
| Frontal Lobe | 1 | 2006 | 120 | 0.060 |
Why?
|
| Pia Mater | 1 | 2005 | 10 | 0.060 |
Why?
|
| Cysteine | 1 | 2006 | 142 | 0.060 |
Why?
|
| Temporal Lobe | 1 | 2006 | 118 | 0.060 |
Why?
|
| Vimentin | 2 | 2022 | 69 | 0.060 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2025 | 43 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 2 | 2001 | 1038 | 0.060 |
Why?
|
| Macrophages | 1 | 2009 | 693 | 0.060 |
Why?
|
| Asthma | 1 | 2012 | 771 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2005 | 106 | 0.060 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2005 | 40 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 153 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2021 | 590 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2006 | 372 | 0.050 |
Why?
|
| Serotonin | 2 | 2003 | 212 | 0.050 |
Why?
|
| Immunoprecipitation | 3 | 2013 | 197 | 0.050 |
Why?
|
| Peptides | 1 | 2008 | 846 | 0.050 |
Why?
|
| Lewy Bodies | 1 | 2003 | 12 | 0.050 |
Why?
|
| In Situ Hybridization | 2 | 2005 | 470 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2025 | 329 | 0.050 |
Why?
|
| Meclofenamic Acid | 1 | 2003 | 1 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 2444 | 0.050 |
Why?
|
| Point Mutation | 1 | 2005 | 350 | 0.050 |
Why?
|
| Solubility | 2 | 2018 | 125 | 0.050 |
Why?
|
| Benzothiazoles | 2 | 2018 | 31 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2003 | 2494 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 589 | 0.050 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 484 | 0.050 |
Why?
|
| Calcineurin | 2 | 2013 | 62 | 0.050 |
Why?
|
| Mesencephalon | 1 | 2003 | 39 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2003 | 251 | 0.050 |
Why?
|
| Rats, Wistar | 2 | 2013 | 329 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2013 | 144 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 1672 | 0.050 |
Why?
|
| Bacteria | 1 | 2006 | 522 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2006 | 571 | 0.050 |
Why?
|
| Transgenes | 2 | 2018 | 336 | 0.050 |
Why?
|
| Aging | 1 | 2009 | 1253 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2003 | 295 | 0.050 |
Why?
|
| Proteome | 1 | 2003 | 278 | 0.050 |
Why?
|
| Protein Aggregates | 1 | 2021 | 35 | 0.040 |
Why?
|
| Thymidine | 1 | 2001 | 53 | 0.040 |
Why?
|
| Tritium | 1 | 2001 | 112 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2008 | 1581 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2008 | 917 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2021 | 46 | 0.040 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2021 | 19 | 0.040 |
Why?
|
| Mutagens | 1 | 2021 | 48 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 452 | 0.040 |
Why?
|
| Materials Testing | 1 | 2021 | 78 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2003 | 454 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 326 | 0.040 |
Why?
|
| Cell Communication | 1 | 2001 | 187 | 0.040 |
Why?
|
| Protein Folding | 1 | 2021 | 224 | 0.040 |
Why?
|
| Particle Size | 1 | 2021 | 149 | 0.040 |
Why?
|
| Posterior Cerebral Artery | 1 | 2020 | 6 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2018 | 3873 | 0.040 |
Why?
|
| Ligands | 1 | 2021 | 495 | 0.040 |
Why?
|
| Microscopy, Ultraviolet | 1 | 2019 | 1 | 0.040 |
Why?
|
| Cell Count | 1 | 2000 | 234 | 0.040 |
Why?
|
| Microtomy | 1 | 2019 | 3 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 1997 | 0.040 |
Why?
|
| Cell Division | 1 | 2001 | 744 | 0.040 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 1723 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 4725 | 0.040 |
Why?
|
| Pattern Recognition, Automated | 1 | 2019 | 49 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2013 | 13017 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2020 | 190 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2012 | 138 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2019 | 102 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2021 | 732 | 0.040 |
Why?
|
| Fetus | 1 | 2002 | 598 | 0.040 |
Why?
|
| Microcirculation | 1 | 2019 | 117 | 0.040 |
Why?
|
| Clusterin | 1 | 2018 | 11 | 0.040 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2021 | 189 | 0.040 |
Why?
|
| Mass Spectrometry | 3 | 2005 | 356 | 0.040 |
Why?
|
| Computer Graphics | 1 | 2018 | 38 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 368 | 0.040 |
Why?
|
| Male | 8 | 2013 | 64918 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2005 | 828 | 0.040 |
Why?
|
| Cell Survival | 2 | 2013 | 869 | 0.030 |
Why?
|
| Genotype | 2 | 2018 | 2706 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2013 | 1085 | 0.030 |
Why?
|
| Stem Cells | 1 | 2002 | 732 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 503 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 492 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 615 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2020 | 530 | 0.030 |
Why?
|
| Protein Binding | 2 | 2012 | 1735 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2007 | 53 | 0.030 |
Why?
|
| Heterozygote | 1 | 2018 | 716 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 3778 | 0.030 |
Why?
|
| Gene Expression | 1 | 2000 | 1564 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2015 | 246 | 0.030 |
Why?
|
| Binding Sites | 2 | 2008 | 1256 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2015 | 383 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2002 | 1975 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 764 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 2674 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2005 | 115 | 0.030 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2013 | 7 | 0.030 |
Why?
|
| Lentivirus | 1 | 2013 | 82 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2013 | 341 | 0.030 |
Why?
|
| Age Factors | 2 | 2013 | 2922 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2013 | 117 | 0.020 |
Why?
|
| Phosphatidylethanolamines | 1 | 2012 | 22 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 425 | 0.020 |
Why?
|
| Formoterol Fumarate | 1 | 2012 | 29 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 2012 | 35 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 432 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2013 | 173 | 0.020 |
Why?
|
| Long-Term Potentiation | 1 | 2013 | 110 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2013 | 121 | 0.020 |
Why?
|
| Mucins | 1 | 2012 | 72 | 0.020 |
Why?
|
| Neuroimaging | 1 | 2016 | 375 | 0.020 |
Why?
|
| Biomarkers | 1 | 2022 | 3380 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 699 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2013 | 99 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2013 | 251 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2012 | 149 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2013 | 295 | 0.020 |
Why?
|
| Bronchi | 1 | 2012 | 103 | 0.020 |
Why?
|
| Exercise Test | 1 | 2013 | 256 | 0.020 |
Why?
|
| Administration, Intravenous | 1 | 2012 | 159 | 0.020 |
Why?
|
| Liver | 1 | 2019 | 1806 | 0.020 |
Why?
|
| Memory, Short-Term | 1 | 2013 | 142 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 243 | 0.020 |
Why?
|
| Epinephrine | 1 | 2012 | 155 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2013 | 226 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 351 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2012 | 158 | 0.020 |
Why?
|
| Lung | 1 | 2019 | 1556 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2013 | 332 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 691 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1008 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 251 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 1724 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 880 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1351 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2008 | 3698 | 0.020 |
Why?
|
| Aged | 3 | 2013 | 21413 | 0.020 |
Why?
|
| Kidney | 1 | 2015 | 1333 | 0.020 |
Why?
|
| Cricetulus | 1 | 2008 | 93 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 396 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2008 | 301 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2007 | 89 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 2006 | 11 | 0.020 |
Why?
|
| Codon, Terminator | 1 | 2006 | 27 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2006 | 57 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 1292 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2008 | 213 | 0.020 |
Why?
|
| RNA Stability | 1 | 2006 | 83 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 749 | 0.010 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2005 | 15 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2008 | 584 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2005 | 253 | 0.010 |
Why?
|
| Celecoxib | 1 | 2005 | 32 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2005 | 47 | 0.010 |
Why?
|
| Fenofibrate | 1 | 2005 | 61 | 0.010 |
Why?
|
| Thiazoles | 1 | 2005 | 99 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2006 | 475 | 0.010 |
Why?
|
| rho-Associated Kinases | 1 | 2005 | 51 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 2902 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 2553 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 618 | 0.010 |
Why?
|
| Receptor, ErbB-4 | 1 | 2003 | 9 | 0.010 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2003 | 5 | 0.010 |
Why?
|
| Hypolipidemic Agents | 1 | 2005 | 189 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 69 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2003 | 159 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 999 | 0.010 |
Why?
|
| DNA Damage | 1 | 2006 | 513 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2005 | 282 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 2003 | 78 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 4541 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2005 | 330 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 1613 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 579 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 868 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 66 | 0.010 |
Why?
|
| Indomethacin | 1 | 2001 | 82 | 0.010 |
Why?
|
| Ibuprofen | 1 | 2001 | 41 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2006 | 930 | 0.010 |
Why?
|
| Exons | 1 | 2003 | 802 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 1047 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 1425 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 1597 | 0.010 |
Why?
|
| Middle Aged | 1 | 2008 | 28936 | 0.000 |
Why?
|